Pharmacy OneSource Blog

Weekly Healthcare Roundup: CDC Funds Projects to Combat Antibiotic Resistance, Reevaulating 30-Day Hospital Readmission Measure

Posted on 10/13/16

evidence_based_strategies_that_can_help_healthcare_quality_improvement.jpg

Here are some of this week's top headlines in healthcare:

Healthcare Industry, Pharmacy and Infection Prevention News

  • CDC Funds 34 Innovative Projects to Combat Antibiotic Resistance
    Infection Control Today
  • UV light disinfection reduces C. diff in patient rooms, study finds
    UPI
  • Further Evidence of Link Between Guillain-Barre Paralysis Syndrome and Zika Virus Infection, Study Finds
    ABC News
  • Reporting of adverse events in targeted therapy and immunotherapy trials is "suboptimal"
    Medical News Today
  • 30-Day Hospital Readmission is a Poor Measure of Quality, New Research Finds
    Infection Control Today
  • Hospitals struggling against 'C. diff' bacteria
    Philly.com
  • Mylan to pay $465M settlement over Medicaid EpiPen rebates
    Associated Press
FDA Approvals, New Drug Applications and Notices
  • FDA approves Orexo’s low-dose Zubsolv
    Drug Store News
  • FDA grants approval for LBT's APAS
    Reuters
  • KemPharm's KP415 IND Accepted by U.S. FDA
    Street Insider
  • Allergan says FDA accepts supplemental new drug application for avycaz
    Reuters
boost_the_value_of_your_emr_with_a_clinical_surveillance_system

Topics: Weekly Healthcare Roundup

About the Author

Heather Quitos is the Digital Marketing Manager for Pharmacy OneSource.